Advanzeon Solutions, Inc. (CHCR) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
DELISTED
What happened to Advanzeon Solutions, Inc. (CHCR) stock?
Advanzeon Solutions, Inc. (CHCR) no longer trades on public markets. The figures below are historical and are not a current quote.
Beta 1.24: the stock has moved about 24% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Advanzeon Solutions, Inc. (CHCR). Advanzeon Solutions, Inc., operating through its subsidiary, focuses on administering and operating the SleepMaster Solutions sleep apnea program. The company filed for Chapter 11 bankruptcy in 2020 and currently trades on the OTC market. Sector: Healthcare.
Last analyzed: Mar 16, 2026Analyst Coverage for CHCR: CHCR does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CHCR against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
CHCR: this read rests on a single discipline (Legends Council) — the other council disciplines have no scored data yet.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Advanzeon Solutions, Inc. (CHCR) Healthcare & Pipeline Overview
Advanzeon Solutions, Inc. operates in the healthcare sector, focusing on sleep apnea program administration through its SleepMaster Solutions. Currently trading on the OTC market after a Chapter 11 filing, the company faces challenges in a competitive medical care facilities landscape.
What Is the Investment Thesis for CHCR?
Investing in Advanzeon Solutions, Inc. (CHCR) presents significant risks due to its OTC market listing and recent Chapter 11 bankruptcy filing in 2020. The company's reliance on the SleepMaster Solutions program for revenue makes it vulnerable to market shifts and competition. With a market capitalization of $0.00B and a beta of 1.24, CHCR exhibits high volatility. Potential investors should closely monitor the company's restructuring efforts and ability to regain financial stability. Growth catalysts are uncertain, and the company's future depends on successfully navigating its bankruptcy proceedings and re-establishing a competitive position in the healthcare sector.
Based on FMP financials and quantitative analysis
CHCR Key Highlights
Advanzeon Solutions, Inc. operates the SleepMaster Solutions sleep apnea program.
- The company filed for Chapter 11 bankruptcy on September 7, 2020.
- CHCR trades on the OTC market, indicating higher risk and lower liquidity.
- The company's market capitalization is $0.00B, reflecting its distressed financial state.
- The company's beta is 1.24, indicating higher volatility than the market.
Who Are CHCR's Competitors?
CHCR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MNDR Mobile-health Network Solutions Class A Ordinary Shares | $1.48 | -0.52% | — | |
| CCM Concord Medical Services Holdings Limited | $3.95 | -4.13% | — | |
| AMS American Shared Hospital Services | $1.48 | +0.68% | $9.80M | 465-pillar |
| PIII P3 Health Partners Inc. | $8.36 | -0.71% | $27.4M | — |
| CCEL Cryo-Cell International, Inc. | $4.13 | +0.49% | $33.3M | 315-pillar |
| DCGO DocGo Inc. | $0.35 | -3.53% | $34.8M | — |
| BTMD biote Corp. | $1.31 | -9.66% | $57.8M | 665-pillar |
| JYNT The Joint Corp. | $8.03 | -0.74% | $114M | 705-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CHCR's Key Strengths?
Specialized SleepMaster Solutions program.
- Experience in sleep apnea program administration.
- Established presence in the healthcare sector.
- Focus on a specific medical condition.
What Are CHCR's Weaknesses?
Recent Chapter 11 bankruptcy filing.
- OTC market listing indicating higher risk.
- Limited market capitalization.
- Reliance on a single product line.
What Could Drive CHCR Stock Higher?
Successful restructuring and emergence from Chapter 11 bankruptcy could restore investor confidence.
- Expansion of the SleepMaster Solutions program into new markets could drive revenue growth.
- Strategic partnerships with healthcare providers could enhance market penetration.
What Are the Key Risks for CHCR?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Financial instability due to Chapter 11 bankruptcy.
- Intense competition in the medical care facilities industry.
- Regulatory changes and reimbursement pressures.
- Limited liquidity and high volatility due to OTC market listing.
- Dependence on a single product line (SleepMaster Solutions).
What Are the Growth Opportunities for CHCR?
- Expansion of Sleep Apnea Program: Advanzeon could focus on expanding its SleepMaster Solutions program by targeting new geographic markets and patient demographics. The global sleep apnea devices market is projected to reach $5.2 billion by 2027, offering a substantial growth opportunity. Success depends on effective marketing, strategic partnerships, and demonstrating superior patient outcomes.
- Telehealth Integration: Integrating telehealth services into the SleepMaster Solutions program could enhance accessibility and convenience for patients, particularly in remote areas. The telehealth market is experiencing rapid growth, driven by technological advancements and increasing demand for remote healthcare solutions. This integration could improve patient engagement and reduce operational costs.
- Strategic Partnerships: Forming strategic alliances with healthcare providers, insurance companies, and sleep clinics could expand Advanzeon's reach and market penetration. Partnerships can provide access to new patient referrals, distribution channels, and reimbursement opportunities. Successful partnerships require alignment of goals, clear communication, and mutual benefit.
- Product Diversification: Diversifying beyond sleep apnea treatment into related respiratory care services could broaden Advanzeon's revenue streams and reduce its reliance on a single product line. This could include offering diagnostic services, respiratory therapy, and home healthcare solutions. Diversification requires careful market research, investment in new technologies, and skilled personnel.
- Cost Optimization: Implementing cost-saving measures and streamlining operations could improve Advanzeon's financial performance and enhance its competitiveness. This includes optimizing supply chain management, reducing administrative expenses, and improving operational efficiency. Cost optimization is crucial for companies facing financial challenges and can improve profitability and cash flow.
What Are CHCR's Competitive Advantages?
- Proprietary SleepMaster Solutions program.
- Established relationships with healthcare providers.
- Experience in sleep apnea program administration.
- Focus on specialized care services.
What Does CHCR Do?
Advanzeon Solutions, Inc., formerly known as Comprehensive Care Corporation, was established in 1969 and rebranded in January 2014. Headquartered in Tampa, Florida, the company operates through its subsidiary, Pharmacy Value Management Solutions, Inc., which administers and manages the SleepMaster Solutions program, a sleep apnea treatment service. Advanzeon's core business revolves around providing solutions for individuals suffering from sleep apnea, a prevalent condition affecting millions. However, on September 7, 2020, Advanzeon Solutions, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida, impacting its operational and financial stability. The company's long-term viability hinges on its ability to restructure and regain market confidence while navigating the competitive landscape of the medical care facilities industry.
What Products and Services Does CHCR Offer?
- Administers and operates the SleepMaster Solutions sleep apnea program.
- Provides solutions for individuals suffering from sleep apnea.
- Operates through its subsidiary, Pharmacy Value Management Solutions, Inc.
- Offers sleep apnea treatment services.
- Focuses on managing sleep apnea programs.
- Aims to improve the quality of life for sleep apnea patients.
How Does CHCR Make Money?
- Generates revenue through the SleepMaster Solutions program.
- Provides sleep apnea treatment services to patients.
- Partners with healthcare providers and insurance companies.
- Focuses on program administration and management.
What Industry Does CHCR Operate In?
Advanzeon Solutions, Inc. operates within the medical care facilities industry, a segment of the broader healthcare sector. This industry is characterized by increasing demand for specialized care services, including sleep apnea treatment. However, the competitive landscape is intense, with established players and emerging technologies vying for market share. Advanzeon's position is challenged by its recent bankruptcy filing and the need to restructure its operations. The industry is also subject to regulatory changes and reimbursement pressures, further impacting the company's prospects.
Who Are CHCR's Key Customers?
- Individuals suffering from sleep apnea.
- Healthcare providers and sleep clinics.
- Insurance companies covering sleep apnea treatment.
- Patients seeking solutions for sleep-related breathing disorders.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price 5 days old
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 4 snapshots
| 2026-08-23 | 46 |
| 2026-08-24 | 46 |
| 2026-08-25 | 46 |
| 2026-08-26 | 46 |
What changed?
The score has stayed at 46.
Over the same 3 days the stock moved +0.0%.
Company Profile
Advanzeon Solutions, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Tampa, US. The company is led by CEO Clark A. Marcus. CHCR has traded publicly since 1975.
Financial Health
Advanzeon Solutions, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Insider Activity
The most recent 6 insider filings for Advanzeon Solutions, Inc. break down as 0 sales and 6 purchases. On net that is roughly 463K shares acquired (about $124K) — insiders putting money in tends to read as conviction.
CHCR Financials
Bull Case vs Bear Case
Bull Case
- Specialized SleepMaster Solutions program.
- Experience in sleep apnea program administration.
- Established presence in the healthcare sector.
- Focus on a specific medical condition.
Bear Case
- Recent Chapter 11 bankruptcy filing.
- OTC market listing indicating higher risk.
- Limited market capitalization.
- Reliance on a single product line.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
CHCR Latest News
No recent news available for CHCR.
Leadership: Clark A. Marcus
Managing Director
Clark A. Marcus serves as the Managing Director of Advanzeon Solutions, Inc. His role involves overseeing the company's operations and strategic direction. As the managing director, he is responsible for the overall performance and management of the company, particularly during its restructuring phase following the Chapter 11 filing.
Track Record: Due to limited information available, Clark A. Marcus's specific achievements and strategic decisions at Advanzeon Solutions, Inc. His tenure is marked by the company's Chapter 11 bankruptcy filing in 2020, indicating significant challenges during his leadership. Evaluating his long-term impact requires further information on the company's restructuring efforts and future performance.
CHCR OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Advanzeon Solutions, Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited reporting requirements and may be undergoing financial distress or restructuring. Unlike NYSE or NASDAQ-listed companies, OTC Other stocks generally have less stringent listing requirements, leading to increased risk and volatility for investors. This tier signifies a higher level of caution is warranted due to the potential for limited information and regulatory oversight.
- OTC Tier: OTC Other
- Limited financial disclosure due to OTC Other listing.
- High price volatility and potential for manipulation.
- Risk of delisting or trading suspension.
- Limited liquidity and wide bid-ask spreads.
- Potential for fraud or mismanagement.
- Verify the company's financial statements and SEC filings (if any).
- Assess the company's management team and their track record.
- Evaluate the company's business model and competitive landscape.
- Review the company's legal and regulatory compliance.
- Analyze the company's debt and cash flow situation.
- Monitor news and press releases for updates on the company's restructuring efforts.
- Consult with a financial advisor before investing.
- Established history since 1969.
- Operation of the SleepMaster Solutions program.
- Presence in the healthcare sector.
- Continued efforts to restructure after bankruptcy.
- Existence of a subsidiary, Pharmacy Value Management Solutions, Inc.
Common Questions About CHCR (Healthcare)
What happened to Advanzeon Solutions, Inc. (CHCR) stock?
Advanzeon Solutions, Inc. (CHCR) no longer trades on public markets. The figures below are historical and are not a current quote.
Can I still buy CHCR shares?
No. CHCR stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for CHCR elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before CHCR stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Advanzeon Solutions, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Advanzeon Solutions, Inc. do?
Advanzeon Solutions, Inc., through its subsidiary Pharmacy Value Management Solutions, Inc., administers and operates the SleepMaster Solutions program, which provides sleep apnea treatment services.
What do analysts say about CHCR stock?
Given Advanzeon Solutions, Inc.'s OTC listing and recent bankruptcy filing, formal analyst coverage is unlikely. Key valuation metrics are difficult to assess due to the company's financial instability. Investors should conduct thorough due diligence and consider the significant risks associated with this stock.
What are the main risks for CHCR?
The main risks for Advanzeon Solutions, Inc. include its ongoing Chapter 11 bankruptcy proceedings, which create uncertainty about its future viability. Its OTC market listing indicates higher risk and lower liquidity. The company's reliance on the SleepMaster Solutions program makes it vulnerable to competition and market shifts.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is limited due to the company's OTC listing and bankruptcy filing.
- Financial data may not be readily available or reliable.
- Analyst coverage is unlikely given the company's financial condition.